Download
s11658-020-00211-2.pdf 1,08MB
WeightNameValue
1000 Titel
  • Metabolic host response and therapeutic approaches to influenza infection
1000 Autor/in
  1. Keshavarz, Mohsen |
  2. Solaymani-Mohammadi, Farid |
  3. Namdari, Haideh |
  4. Arjeini, Yaser |
  5. Mousavi, Mohammad Javad |
  6. Rezaei, Farhad |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-03-05
1000 Erschienen in
1000 Quellenangabe
  • 25:15
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s11658-020-00211-2 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059726/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Based on available metabolomic studies, influenza infection affects a variety of cellular metabolic pathways to ensure an optimal environment for its replication and production of viral particles. Following infection, glucose uptake and aerobic glycolysis increase in infected cells continually, which results in higher glucose consumption. The pentose phosphate shunt, as another glucose-consuming pathway, is enhanced by influenza infection to help produce more nucleotides, especially ATP. Regarding lipid species, following infection, levels of triglycerides, phospholipids, and several lipid derivatives undergo perturbations, some of which are associated with inflammatory responses. Also, mitochondrial fatty acid β-oxidation decreases significantly simultaneously with an increase in biosynthesis of fatty acids and membrane lipids. Moreover, essential amino acids are demonstrated to decline in infected tissues due to the production of large amounts of viral and cellular proteins. Immune responses against influenza infection, on the other hand, could significantly affect metabolic pathways. Mainly, interferon (IFN) production following viral infection affects cell function via alteration in amino acid synthesis, membrane composition, and lipid metabolism. Understanding metabolic alterations required for influenza virus replication has revealed novel therapeutic methods based on targeted inhibition of these cellular metabolic pathways.
1000 Sacherschließung
lokal Glycolysis
lokal Indoleamine-2,3-dioxygenase
lokal Influenza
lokal Fatty acid synthesis
lokal Metabolism
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/S2VzaGF2YXJ6LCBNb2hzZW4=|https://frl.publisso.de/adhoc/uri/U29sYXltYW5pLU1vaGFtbWFkaSwgRmFyaWQ=|https://frl.publisso.de/adhoc/uri/TmFtZGFyaSwgSGFpZGVo|https://frl.publisso.de/adhoc/uri/QXJqZWluaSwgWWFzZXI=|https://frl.publisso.de/adhoc/uri/TW91c2F2aSwgTW9oYW1tYWQgSmF2YWQ=|https://frl.publisso.de/adhoc/uri/UmV6YWVpLCBGYXJoYWQ=
1000 Label
1000 Förderer
  1. Tehran University of Medical Sciences and Health Services |
1000 Fördernummer
  1. 38839
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Tehran University of Medical Sciences and Health Services |
    1000 Förderprogramm -
    1000 Fördernummer 38839
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6424013.rdf
1000 Erstellt am 2020-11-04T15:07:55.940+0100
1000 Erstellt von 218
1000 beschreibt frl:6424013
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet 2020-11-06T09:56:44.994+0100
1000 Objekt bearb. Fri Nov 06 09:56:27 CET 2020
1000 Vgl. frl:6424013
1000 Oai Id
  1. oai:frl.publisso.de:frl:6424013 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source